Upload
mohit-khandelwal
View
216
Download
0
Embed Size (px)
Citation preview
8/11/2019 Forbes India Magazine - Ready to Germinate
1/3
Copyright 2011, Forbseindia.com
by Rohin Dharmakumar | Aug 7, 2009
The boffins who left biotech firm Monsanto in 2001 are now ready to take it on
K.K. Narayanan was stunned. Why do you need VC money? Instead pledge your cars or wives jewellery, like we did at Infosys, he was
told. And Narayanan thought that N.S. Raghavan, one of the co-founders, of Infosys, would understand a bunch of bright biotech
scientists.
Narayanan and his colleagues Gautham Nadig and Ganesh Kishore persisted and Raghavan gave them Rs. 6.5 crore to start
Metahelix, an agricultural biotech company, in 2001. I made a gut call based on their qualifications and experience at Monsanto, says
Raghavan. He might as well add ambition to that quality.
After eight years Metahelix is ready to compete and guess who is on the other side of the net? The big daddy of genetically modified seeds,
Monsanto. This is the moment of truth for Raghavans gut and Narayanans execution.
The Rs. 7,000 crore Indian market for agricultural seeds is the fifth largest in the world. Of that, roughly Rs. 2,000 crore is the market for
cotton seeds. This is the market Metahelix is targetting. Nadig says a 10 percent market share is what Metahelix will be gunning for in thenext three to five years.
Based on todays market and prices, that would mean Rs. 200 crore in revenue.
Over 90 percent of Metahelixs target market is transgenic, or genetically modified (GM). And 95 percent of those seeds contain
technology from one company Monsanto. Monsanto is the Coca-Cola of GM seeds business.
Based on proprietary genes derived from the Bacillus Thuringiensis (Bt.) bacteria, Monsanto makes the secret sauce or the
concentrate that makes a seed resistant to bollworms and armyworms, both nasty vermins. It licences the concentrate to companies
like Rasi, Nuziveedu, Ankur, and Mahyco that are like the local bottling company of Coca Cola. These guys add other features like usage
of water, fast breeding time (based on local farmers needs) to the concentrate and then handle the distribution and selling of the seed to
the farmers.
For example, a hybrid for Andhra Pradeshs (AP) Telengana district will make do with lesser water (the area is mostly rain-fed), fertilizer
(most farmers are poor) while maturing faster (poor farmers prefer quicker yields). In comparison, the hybrid for APs coastal districts
will mature slower (so they have time to absorb the nutrients over time) and offer better yields (most farmers are rich, and their plots are
irrigated).
Thats why even though there are only five commercial Bt. variants in the country (two from Monsanto, one each from JK, Nath and
Metahelix), there are over 300 different branded cotton hybrids that are sold. Almost all of these contain the Bt. gene Monsantos in
over 90 percent cases but the variety is in the hybrid features, the localisation as it were.
A Masterstroke
If Metahelix has to take on Monsanto then the battle is clearly split in two phases. The first phase is to come up with a concentrate that
can rival Monsantos. This it has done. It is the first company globally to isolate and use a completely new Bt. gene segment, cry1C, in
cotton seed.
Metahelixs new seed offers protection against both the Lepidoptera and Spodoptera pest families, placing it on a strong footing against
first generation Bt. cotton seeds which target only the former pest family.
Metahelixs seeds have undergone a stringent series of trials across India since 2005. In July, two of Metahelixs Bt. cotton seeds, 5125Bt
and 5174Bt, received official approval for commercial use in central and south India. But the approval was too late for this years kharif
sowing season.
Conventionally, the way Indian scientist-backed start-ups behave, now would be the time for nerds to give way to the suits who would
start looking for distribution tie-ups. Metahelix doesnt have to do that.
Why? Because it already has a distribution company called Dhaanya Seeds. Dhaanya Seeds is a commercial masterstroke. From a Rs. 3
crore turnover in 2003 the company is now Rs. 80 crore in turnover. It sells normal non-Bt. seeds for rice, sunflower, tomato and
brinjal.
Dhaanya has provided Metahelix with two strong advantages. It has created the distribution platform for the companys Bt. cotton seed
now that it is ready to be sold. It also provides a steady stream of money to fund R&D. This is where the business acumen of this team
shows through.
The DifferentiatorWhen Metahelix started, it needed money to fund its research and clearly angel funding was not enough. So the company started doing
contract research research for other companies. This brought in the cash but diverted company resources away from their own seed
research programme. One of the first people to spot this shift was N.S. Raghavan.
In the early days of outsourcing, we at Infosys refused to agree to GEs conditions that all the code we generated would be theirs. Even as
bes India Magazine - Ready to Germinate http://forbesindia.com/printcontent/2812?id=2812
3 8/14/2014 11:54 AM
8/11/2019 Forbes India Magazine - Ready to Germinate
2/3
all other vendors agreed we stood our ground, because we felt that owning some elements of the code was critical for us to build a more
robust, re-usable delivery platform, says Raghavan.
But doing away with contract research meant Metahelix would need to find an alternate revenue source, so that its R&D would not suffer.
Thats why Dhaanya Seeds was created. The cash-flow from Dhaanya allowed Metahelix scientists to concentrate on their own R&D. That
bore fruit when they became the first company in the world to isolate and use a completely new Bt. gene segment, cry1C, in the cotton
seed.
So Metahelix has the product and the distribution. Still, that may not be sufficient. When they do enter the market, gone will be the
low-hanging fruit of converting non-Bt. farmers to Bt. ones. That battle is already over, for Monsanto won it. The Indian cotton marketis almost fully penetrated by Bt. cotton, says Jagresh Rana, director at Mahyco Monsanto Biotech (MMB), the joint venture between
Indian seed company Mahyco and Monsanto which licences the latters Bt. cotton in India. The trend today is farmers shifting from the
first to second generation Bt. technologies, he says.
When that happens, says Nadig, insect protection will become a given and therefore cease to be a differentiator. The focus will move to
other areas.
Sometimes in the midst of all these technologies we forget that farmers dont grow cotton to kill pests, but to get a better yield, says
Narayanan. If Metahelix can engineer a hybrid that can grow faster, utilise nutrient-s more effectively or produce a better yield, that
might be its differentiator. This opinion is shared by Suman Sahai, convener of rural advocacy group Gene Campaign. The success of Bt.
cotton in India owes as much to the hybrids developed by Rasi and Nuziveedu, as to Monsantos technology. In fact, MMBs initial seeds
which were the first to get government approval were spectacular failures, she says.
Challenges Ahead
Dhaanya claims that both the cotton hybrids it has developed (5125 for rain-fed areas and 5174 for irrigated areas) have demonstratedbetter traits like cotton boll size, the length of the fibre (staple) and rejuvenation (ability to withstand longer periods without water)
during field trials.
Therefore, when it goes to the market next year, its strategy will be two-pronged: Convince farmers using Bollgard-1 cotton (the first
generation of Bt. seeds) to upgrade to Metahelixs seed which offers added protection against pests, and demonstrate to Bollgard-2
(second generation Bt. seeds) farmers how their hybrid varieties offer better yields while offering the same level of pest protection.
In order to do this it is organising demonstrations of its cotton crops in over 250 locations around the country, where farmers will be
allowed to examine Metahelixs claims through live crops. It is also combining this with village-level meetings where company
representatives will explain the benefits of their products over the competition.
How successful we are in year 1 will depend on the trade channels and our village level demos, says Ravi Krishna, head of Dhaanya.
But if the crop is successful, then from year 2 onwards each of our original customers will become a reference for added sales.
Its first year crop will also demonstrate the pest resistance ability vis--vis Bollgard-1 and 2. And if it holds up, some seed companies maybe tempted to jump ship from Monsanto to Metahelix as the source for the Bt. gene.
Most seed companies are today aligned with Monsanto, which we may not be able to break immediately, says Krishna. Though a few
have approached us to sub-licence our technology, we refused. We would prefer to show actual results before tying up with other seed
companies.
And while pest protection may soon become a given, pricing already has. For all practical purposes the price of Bt. cotton is fixed at Rs.
650 (for Bollgard-1) and Rs. 750 (for Bollgard-2) in various states, a matter that Monsanto is fighting in the courts.
This money is shared between Monsanto and the seed companies that licence its technology into their own hybrids. It is here that
Metahelix may have an advantage as its cost of developing the Bt. cotton technology is only around a fourth of Monsantos. In the
immediate term it means Dhaanya will have the freedom to sell at a lower price (though Metahelix says it has not evaluated that decision
yet), but more importantly, in the longer term it means Metahelix might be able to offer a lower technology licence fee to other seed
companies for its Bt. cotton.
In a volume-led market even a few hundred rupees per packet could alter the equation dramatically. But if Metahelix can convert a few
leading seed companies to use its Bt. gene, it might be an added inflection point for the company.
Fact File
The Company:Agricultural biotech company, Metahelix.
The Opportunity:A Rs. 2,000 crore Indian market for cotton seeds
The Target:Capture 10 percent market share over next 3-5 years. Thats Rs. 200 crore in revenue based on todays market and prices.
Strengths:It has the product its own version of a genetically modified cotton seed, which is cheaper and offers added protection
against pests.
The Challenge:Breaking into a market that is controlled by the worlds largest player in genetically modified seeds, Monsanto.
Bt. Coton Blues
Rapid adoption of genetically modified (GM) seeds has left many environmentalists aghast, as they questioned the long-term effects ofGM crops on human health and the environment.
Suman Sahai, the convener of rural advocacy organisation Gene Campaign, says Bt. cotton was shoved down everyones throats even
though there was no clear demand for it. Not only do GM crops lead to massive buildup of resistance among pests, there is growing
evidence that its toxins affect many other organisms than the ones they are targeted at.
bes India Magazine - Ready to Germinate http://forbesindia.com/printcontent/2812?id=2812
3 8/14/2014 11:54 AM
8/11/2019 Forbes India Magazine - Ready to Germinate
3/3
But many leading scientists are questioning that viewpoint. G. Padmanabhan, former director at IISc. Bangalore says, In India both land
and water are limited, so the time has come to make the plant the centre of our focus to ensure adequate yields. But then I see Mahesh
Bhatt on TV campaigning against Bt. brinjal, and I realise there is no way we scientists can match that.
This article appeared in Forbes India Magazine of 14 August, 2009
bes India Magazine - Ready to Germinate http://forbesindia.com/printcontent/2812?id=2812
3 8/14/2014 11:54 AM